| Genetic determination of irritable bowel syndrome C Hotoleanu, R Popp, AP Trifa, L Nedelcu, DL Dumitrascu World journal of gastroenterology: WJG 14 (43), 6636, 2008 | 74 | 2008 |
| How to diagnose and treat a cancer of unknown primary site. C Tomuleasa, F Zaharie, MS Muresan, L Pop, Z Fekete, D Dima, I Frinc, ... Journal of Gastrointestinal & Liver Diseases 26 (1), 2017 | 64 | 2017 |
| Analysis of CYP2C9*2, CYP2C9*3 and VKORC1 ‐1639 G>A polymorphisms in a population from South‐Eastern Europe AD Buzoianu, AP Trifa, DF Mureșanu, S Crișan Journal of cellular and molecular medicine 16 (12), 2919-2924, 2012 | 61 | 2012 |
| CAT, GPX1, MnSOD, GSTM1, GSTT1, and GSTP1 genetic polymorphisms in chronic myeloid leukemia: a case-control study C Bănescu, AP Trifa, S Voidăzan, VG Moldovan, I Macarie, ... Oxidative Medicine and Cellular Longevity 2014, 2014 | 51 | 2014 |
| Polymorphism of XRCC1, XRCC3, and XPD genes and risk of chronic myeloid leukemia C Bănescu, AP Trifa, S Demian, E Benedek Lazar, D Dima, C Duicu, ... BioMed Research International 2014, 2014 | 46 | 2014 |
| The role of medical registries, potential applications and limitations B Pop, B Fetica, ML Blaga, AP Trifa, P Achimas-Cadariu, CI Vlad, ... Medicine and pharmacy reports 92 (1), 7, 2019 | 36 | 2019 |
| TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms … AP Trifa, C Bănescu, M Tevet, A Bojan, D Dima, L Urian, T Török‐Vistai, ... British Journal of Haematology 174 (2), 218-226, 2016 | 35 | 2016 |
| MECOM, HBS1L‐MYB, THRB‐RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients AP Trifa, C Bănescu, AS Bojan, CM Voina, Ș Popa, S Vișan, AD Ciubean, ... American Journal of Hematology 93 (1), 100-106, 2018 | 34 | 2018 |
| The G allele of the JAK2 rs10974944 SNP, part of JAK2 46/1 haplotype, is strongly associated with JAK2 V617F-positive myeloproliferative neoplasms AP Trifa, A Cucuianu, L Petrov, L Urian, MS Militaru, D Dima, IV Pop, ... Annals of hematology 89, 979-983, 2010 | 33 | 2010 |
| Prevalence of the c. 35delG and p. W24X mutations in the GJB2 gene in patients with nonsyndromic hearing loss from North-West Romania C Lazăr, R Popp, A Trifa, C Mocanu, G Mihut, C Al-Khzouz, E Tomescu, ... International journal of pediatric otorhinolaryngology 74 (4), 351-355, 2010 | 33 | 2010 |
| From six gene polymorphisms of the antioxidant system, only GPX Pro198Leu and GSTP1 Ile105Val modulate the risk of acute myeloid leukemia C Bănescu, M Iancu, AP Trifa, M Cândea, E Benedek Lazar, ... Oxidative Medicine and Cellular Longevity 2016, 2016 | 31 | 2016 |
| Vitamin D receptor polymorphisms and melanoma AF Vasilovici, LE Grigore, L Ungureanu, O Fechete, E Candrea, AP Trifa, ... Oncology Letters 17 (5), 4162-4169, 2019 | 30 | 2019 |
| XRCC1 Arg194Trp and Arg399Gln polymorphisms are significantly associated with shorter survival in acute myeloid leukemia C Bănescu, C Duicu, AP Trifa, M Dobreanu Leukemia & lymphoma 55 (2), 365-370, 2014 | 29 | 2014 |
| Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome A Jurj, L Pop, B Petrushev, S Pasca, D Dima, I Frinc, D Deak, ... Critical Reviews in Clinical Laboratory Sciences 55 (7), 501-515, 2018 | 28 | 2018 |
| An acenocoumarol dose algorithm based on a South-Eastern European population TR Pop, ȘC Vesa, AP Trifa, S Crișan, AD Buzoianu European journal of clinical pharmacology 69, 1901-1907, 2013 | 27 | 2013 |
| Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population C Bănescu, M Iancu, AP Trifa, M Dobreanu, VG Moldovan, C Duicu, ... Tumor Biology 37, 9357-9366, 2016 | 25 | 2016 |
| The relationship between factor V Leiden, prothrombin G20210A, and MTHFR mutations and the first major thrombotic episode in polycythemia vera and essential … AP Trifa, A Cucuianu, RA Popp, CA Coadă, RM Costache, MS Militaru, ... Annals of hematology 93, 203-209, 2014 | 25 | 2014 |
| Phytochemicals in cardiovascular and respiratory diseases: Evidence in oxidative stress and inflammation RM Pop, A Popolo, AP Trifa, LA Stanciu Oxidative Medicine and Cellular Longevity 2018, 2018 | 23 | 2018 |
| The impact of the CYP2C9 and VKORC1 polymorphisms on acenocoumarol dose requirements in a Romanian population AD Buzoianu, FC Militaru, ȘC Vesa, AP Trifa, S Crișan Blood Cells, Molecules, and Diseases 50 (3), 166-170, 2013 | 22 | 2013 |
| 2016 WHO clinical molecular and pathological criteria for classification and staging of myeloproliferative neoplasms (MPN) caused by MPN driver mutations in the JAK2, MPL and … JJ Michiels, M Tevet, A Trifa, E Niculescu-Mizil, A Lupu, AM Vladareanu, ... Maedica 11 (1), 5, 2016 | 20 | 2016 |
